AMGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against ...
Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers or acquirers of Amgen Inc. (NASDAQ: AMGN) common stock between July 29, 2020 and April 27, 2022, inclusive (the “Class Period”). Captioned Roofers Local No. 149 Pension Fund v. Amgen Inc., No. 23-cv-02138 (S.D.N.Y.), the Amgen class action lawsuit charges Amgen as well as certain of Amgen’s top executives with violations of the Securities Exchange Act of 1934
SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers or acquirers of Amgen Inc. (NASDAQ: AMGN) common stock between July 29, 2020 and April 27, 2022, inclusive (the “Class Period”). Captioned Roofers Local No. 149 Pension Fund v. Amgen Inc., No. 23-cv-02138 (S.D.N.Y.), the Amgen class action lawsuit charges Amgen as well as certain of Amgen’s top executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Amgen class action lawsuit, please provide your information here:
You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com. Lead plaintiff motions for the Amgen class action lawsuit must be filed with the court no later than May 12, 2023.